Clinical Trial Update: Brain Imaging of Intranasal Oxytocin Treatment in Autism [Phase 1]

View source ↗

Summary

Phase 1 brain-imaging study of intranasal oxytocin in autism has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Oxytocin (intranasal) (oxytocin)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Autism Spectrum Disorders | Phase 1 | Status: COMPLETED